Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Receivables (2016 - 2026)

Collegium Pharmaceutical has reported Receivables over the past 10 years, most recently at $231.2 million for Q4 2025.

  • For Q4 2025, Receivables fell 8.82% year-over-year to $231.2 million; the TTM value through Dec 2025 reached $231.2 million, down 8.82%, while the annual FY2025 figure was $231.2 million, 8.82% down from the prior year.
  • Receivables for Q4 2025 was $231.2 million at Collegium Pharmaceutical, down from $233.9 million in the prior quarter.
  • Over five years, Receivables peaked at $253.5 million in Q4 2024 and troughed at $90.1 million in Q2 2021.
  • A 5-year average of $181.8 million and a median of $182.5 million in 2022 define the central range for Receivables.
  • Biggest five-year swings in Receivables: surged 119.21% in 2022 and later dropped 15.2% in 2023.
  • Year by year, Receivables stood at $105.8 million in 2021, then skyrocketed by 73.01% to $183.1 million in 2022, then dropped by 1.96% to $179.5 million in 2023, then skyrocketed by 41.23% to $253.5 million in 2024, then decreased by 8.82% to $231.2 million in 2025.
  • Business Quant data shows Receivables for COLL at $231.2 million in Q4 2025, $233.9 million in Q3 2025, and $213.0 million in Q2 2025.